{"id":225252,"date":"2025-11-17T13:07:43","date_gmt":"2025-11-17T19:07:43","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/11\/biotech-solves-for-best-in-class-adc-formula-with-120m-fundraise"},"modified":"2025-11-17T13:07:43","modified_gmt":"2025-11-17T19:07:43","slug":"biotech-solves-for-best-in-class-adc-formula-with-120m-fundraise","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/11\/biotech-solves-for-best-in-class-adc-formula-with-120m-fundraise","title":{"rendered":"Biotech solves for best-in-class ADC formula with $120M fundraise"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/biotech-solves-for-best-in-class-adc-formula-with-120m-fundraise.jpg\"><\/a><\/p>\n<p>A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck &amp; Co. to fuel its efforts.<\/p>\n<p>Solve Therapeutics\u2019 new fundraise was led by oncology-focused VC Yosemite, with participation from new investors Abingworth and Merck, plus existing investors Alexandria Venture Investments and Citadel\u2019s Surveyor Capital, among others.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck &amp; Co. to fuel its efforts. Solve Therapeutics\u2019 new fundraise was led by oncology-focused VC Yosemite, with participation from new investors Abingworth and Merck, plus existing investors Alexandria Venture Investments and [\u2026]<\/p>\n","protected":false},"author":396,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-225252","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/225252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/396"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=225252"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/225252\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=225252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=225252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=225252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}